Patents by Inventor HaiGuang Zhang

HaiGuang Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11917054
    Abstract: Embodiments of this application disclose a network key processing system, including user equipment, a security anchor network element, and an access and mobility management network element, where the security anchor network element is configured to: obtain a first key parameter from a slice selection network element, where the first key parameter includes identifier information of N network slices; generate N slice-dedicated keys based on the first key parameter; and send the N slice-dedicated keys to the corresponding N network slices respectively; the access and mobility management network element is configured to: obtain the first key parameter, and send the first key parameter to the user equipment; and the user equipment is configured to: generate the N slice-dedicated keys for the N network slices based on the first key parameter, and access the N network slices based on the generated N slice-dedicated keys.
    Type: Grant
    Filed: August 11, 2022
    Date of Patent: February 27, 2024
    Assignee: HUAWEI TECHNOLOGIES CO., LTD.
    Inventors: Zhongding Lei, Lichun Li, Bo Zhang, Fei Liu, Haiguang Wang, Xin Kang
  • Patent number: 11623210
    Abstract: A method for preparing a silicate/carbon composite from attapulgite, and use of the silicate/carbon composite are disclosed. The preparation method includes: (1) with attapulgite as a raw material, preparing SiO2 with a special structure; (2) dispersing the prepared SiO2 in water to obtain a suspension, and subjecting the suspension to ultrasonic dispersion; dissolving a metal nitrate in the suspension, adding NH4Cl, and adding ammonia water dropwise to the suspension; and adding sucrose to obtain a suspension; (3) subjecting the suspension to microwave hydrothermal reaction; after the reaction is completed, centrifuging a resulting system; and separating a resulting solid; and (4) subjecting the solid to high-temperature calcination in a muffle furnace, and grinding a resulting product to obtain the silicate/carbon composite, which can be used in photocatalytic ammonia synthesis.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: April 11, 2023
    Assignee: CHANGZHOU UNIVERSITY
    Inventors: Xiazhang Li, Haiguang Zhang, Xini Chu, Jie Zhu, Xiangyu Yan, Shixiang Zuo, Chao Yao, Wenjie Liu, Huihui Mao
  • Patent number: 11583808
    Abstract: A method for preparation of conductive polymer/carbon nanotube (CNT) composite nanofiltration (NF) membrane and the use thereof. This conductive polymer/CNT composite NF membrane is obtained by polymerizing conductive polymer into a CNT membrane and then in-situ cross-linking with glutaraldehyde under acidic condition. The synthetic method for the conductive polymer/CNT composite NF membrane is simple and has no need of expensive equipment. The prepared membrane has controllable membrane structure and possesses superior electrical conductivity and electrochemical stability. The membrane can couple with electrochemistry for electrically assisted filtration. With the electrical assistance, the membrane can achieve improved ion rejection performance while retaining high permeability by enhancement of membrane surface charge density, which alleviates the permeability-selectivity trade-off.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: February 21, 2023
    Assignee: DALIAN UNIVERSITY OF TECHNOLOGY
    Inventors: Xie Quan, Haiguang Zhang, Shuo Chen, Hongtao Yu
  • Publication number: 20220305475
    Abstract: A method for preparing a silicate/carbon composite from attapulgite, and use of the silicate/carbon composite are disclosed. The preparation method includes: (1) with attapulgite as a raw material, preparing SiO2 with a special structure; (2) dispersing the prepared SiO2 in water to obtain a suspension, and subjecting the suspension to ultrasonic dispersion; dissolving a metal nitrate in the suspension, adding NH4Cl, and adding ammonia water dropwise to the suspension; and adding sucrose to obtain a suspension; (3) subjecting the suspension to microwave hydrothermal reaction; after the reaction is completed, centrifuging a resulting system; and separating a resulting solid; and (4) subjecting the solid to high-temperature calcination in a muffle furnace, and grinding a resulting product to obtain the silicate/carbon composite, which can be used in photocatalytic ammonia synthesis.
    Type: Application
    Filed: November 10, 2020
    Publication date: September 29, 2022
    Applicant: CHANGZHOU UNIVERSITY
    Inventors: Xiazhang LI, Haiguang ZHANG, Xini CHU, Jie ZHU, Xiangyu YAN, Shixiang ZUO, Chao YAO, Wenjie LIU, Huihui MAO
  • Publication number: 20210008503
    Abstract: A method for preparation of conductive polymer/carbon nanotube (CNT) composite nanofiltration (NF) membrane and the use thereof. This conductive polymer/CNT composite NF membrane is obtained by polymerizing conductive polymer into a CNT membrane and then in-situ cross-linking with glutaraldehyde under acidic condition. The synthetic method for the conductive polymer/CNT composite NF membrane is simple and has no need of expensive equipment. The prepared membrane has controllable membrane structure and possesses superior electrical conductivity and electrochemical stability. The membrane can couple with electrochemistry for electrically assisted filtration. With the electrical assistance, the membrane can achieve improved ion rejection performance while retaining high permeability by enhancement of membrane surface charge density, which alleviates the permeability-selectivity trade-off.
    Type: Application
    Filed: December 18, 2018
    Publication date: January 14, 2021
    Inventors: Xie QUAN, Haiguang ZHANG, Shuo CHEN, Hongtao YU
  • Patent number: 8426147
    Abstract: Human ROR genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of ROR are provided.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: April 23, 2013
    Assignee: Exelixis, Inc.
    Inventors: Helen Francis-Lang, Lori Friedman, Thomas Kidd, Siobhan Roche, Haiguang Zhang
  • Patent number: 7785805
    Abstract: Human MAN2A genes are identified as modulators of the IGFR pathway and thus are therapeutic targets for disorders associated with defective IGFR function Methods for identifying modulators of IGFR comprising screening for agents that modulate the activity of MAN2A are provided.
    Type: Grant
    Filed: January 27, 2005
    Date of Patent: August 31, 2010
    Assignee: Exelixis, Inc.
    Inventors: Lori Friedman, Helen Francis-Lang, Annette L. Parks, Kenneth James Shaw, HaiGuang Zhang, Timothy S. Heuer
  • Publication number: 20090149413
    Abstract: Human ROR genes are identified as modulators of the p21 pathway, and thus are therapeutic targets for disorders associated with defective p21 function. Methods for identifying modulators of p21, comprising screening for agents that modulate the activity of ROR are provided.
    Type: Application
    Filed: December 1, 2008
    Publication date: June 11, 2009
    Applicant: EXELIXIS INC.
    Inventors: Helen Francis-Lang, Lori Friedman, Thomas Kidd, Siobhan Roche, Haiguang Zhang
  • Publication number: 20080213247
    Abstract: Human MBM genes are identified as modulators of branching morphogenesis, and thus are therapeutic targets for disorders associated with defective branching morphogenesis function. Methods for identifying modulators of branching morphogenesis, comprising screening for agents that modulate the activity of MBM are provided.
    Type: Application
    Filed: October 22, 2003
    Publication date: September 4, 2008
    Inventors: Gregory D. Plowman, Felix D. Karim, Candace Swimmer, Hinrich Alexander Habeck, Thomas I. Koblizek, Stefan Schulte-Merker, Ulrike Langheinrich, Gordon Mark Stott, Torsten Trowe, Andreas Michael Vogel, Joerg Heinrich Odenthal, Jochen Konrad Scheel, Torsten Tilmann Will, Yisheng Jin, Lynn Margaret Bjerke, Bing Hai, Joanne I. Adamkewicz, Kim Licketeig, R. Glenn R. Hammonds, Craig D. Amundsen, Haiguang Zhang, Monique Nicoll
  • Publication number: 20080050313
    Abstract: Human SULF genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of SULF are provided.
    Type: Application
    Filed: August 12, 2004
    Publication date: February 28, 2008
    Applicant: Exelixis, Inc.
    Inventors: Helen Francis-Lang, Christopher G. Winter, Richard Benn Abegania Ventura, HaiGuang Zhang, Timothy S. Heuer
  • Publication number: 20070274914
    Abstract: Human MPTEN genes are identified as modulators of the PTEN/IGF pathway, and thus are therapeutic targets for disorders associated with defective PTEN/IGF function. Methods for identifying modulators of PTEN/IGF, comprising screening for agents that modulate the activity of MPTEN are provided.
    Type: Application
    Filed: May 13, 2004
    Publication date: November 29, 2007
    Inventors: Chunyan Song, Michael Ollmann, Kim Lickteig, HaiGuang Zhang, Lynn Bjerke
  • Publication number: 20070264268
    Abstract: Human MIGFR genes are identified as modulators of the IGFR pathway, and thus are therapeutic targets for disorders associated with defective IGFR function. Methods for identifying modulators of IGFR, comprising screening for agents that modulate the activity of MIGFR are provided.
    Type: Application
    Filed: January 27, 2005
    Publication date: November 15, 2007
    Applicant: EXELIXIS, INC.
    Inventors: Lori Friedman, Helen Francis-Lang, Annette Parks, Kenneth Shaw, HaiGuang Zhang, Timothy Heuer
  • Publication number: 20070128666
    Abstract: Human TBK genes are identified as modulators of the beta catenin pathway, and thus are therapeutic targets for disorders associated with defective beta catenin function. Methods for identifying modulators of beta catenin, comprising screening for agents that modulate the activity of TTBK are provided.
    Type: Application
    Filed: November 23, 2004
    Publication date: June 7, 2007
    Inventors: Helen Francis-Lang, Christopher Winter, Richard Ventura, HaiGuang Zhang, Timothy Heuer
  • Patent number: 6521462
    Abstract: Methods and composition for inducing, detecting and modulating seizure in animal systems are provided. Methods for inducing seizure comprise (1) electrically stimulating an unanesthetized fly and detecting seizure induction in the fly (2) electrically stimulating a fly with less than 10V and detecting seizure induction in the fly; (3) electrically stimulating a population of wild-type flies and detecting seizure induction in most of the flies and (4) electrically stimulating a population of flies and quantitatively detecting seizure induction in the flies across genotypes or experience. Methods for modulating seizure induction comprise changing the activity of a novel seizure regulator in an animal system and confirming a resultant change in seizure inducibility of the system.
    Type: Grant
    Filed: May 16, 2000
    Date of Patent: February 18, 2003
    Assignee: The Regents of the University of California
    Inventors: Mark A. Tanouye, Daniel Kuebler, HaiGuang Zhang